Global Health Ltd

Global Health Ltd has announced that its Board of Directors will convene on November 3, 2026, to approve the unaudited financial results for the second quarter and half year ended September 30, 2026. Concurrently, the company has closed its trading window from October 1, 2026, which will reopen 48 hours after the financial results are declared, in compliance with SEBI regulations.

Global Health Ltd has received an ESG rating of 'Crisil ESG 64' and a Core ESG rating of 'Crisil Core ESG 70' for Fiscal Year 2026 from Crisil ESG Ratings & Analytics Limited. The company was informed of this rating on October 1, 2026, after working hours. Due to a national holiday and the subsequent weekend, Global Health Ltd became aware of the communication on October 5, 2026, and promptly informed the stock exchanges. This rating reflects the company's performance and commitment to environmental, social, and governance factors.

Global Health Limited (Medanta) has acquired a 10,560 sq. meter land parcel in Ghaziabad, Uttar Pradesh, for approximately ₹165.82 crore. This strategic acquisition is intended for the development of a new 350+ bedded hospital, subject to necessary approvals. The proposed facility aims to strengthen Medanta's presence in the Delhi-NCR healthcare ecosystem and cater to the growing demand for advanced medical services in Ghaziabad and surrounding areas. The company views Ghaziabad as a compelling long-term healthcare opportunity due to its expanding population, urbanization, and connectivity.

Global Health Ltd has acquired a land parcel of 10560.36 sq. meters in Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh, for ₹165.82 crores. The land is suitable for constructing a 350+ bedded hospital, subject to necessary approvals. The company's management is currently evaluating the project plan and will seek Board of Directors' approval. This strategic acquisition marks a significant step towards expanding the company's healthcare infrastructure. Further developments will be communicated to the stock exchanges.

Global Health Ltd has announced the closure of its trading window for the second quarter ending September 30, 2026. This closure, in compliance with SEBI regulations and the company's insider trading code, will be effective from October 01, 2026. The window will reopen 48 hours after the declaration of the unaudited financial results for the aforementioned quarter to the stock exchanges. This measure is standard practice to prevent insider trading during periods of sensitive financial information disclosure.

Global Health Limited has announced its 22nd Annual General Meeting (AGM) scheduled for Wednesday, September 16, 2026, at 12:00 Noon. The meeting will be conducted via Video Conference (VC) / Other Audio-Visual Means (OAVM). Electronic copies of the AGM Notice and the Annual Report for FY 2025-26 are being dispatched to shareholders whose email addresses are registered. For shareholders whose email addresses are not registered, the company has provided web links and specific paths to access these documents on its website and stock exchange portals. Key dates include a Record Date of August 14, 2026, for the final dividend of FY 2025-26, and e-voting closing on September 15, 2026. Dividend payment is expected by October 15, 2026.

Global Health Ltd has filed its Business Responsibility and Sustainability Report (BRSR) along with an Assurance Report for the Financial Year 2025-26, as per SEBI regulations. The report details the company's corporate identity, operational footprint, workforce, and stakeholder engagement. Key highlights include a turnover of ₹45,088.60 Million and a total workforce of 14,777, with 50.8% women in the permanent workforce. The company operates six multi-specialty tertiary care hospitals under the 'Medanta' brand across India. The report covers disclosures on general, management, and principle-wise performance, linking business activities to UN SDGs and various capital types.

Global Health Ltd has submitted its Annual Report, including the Business Responsibility and Sustainability Report (BRSR), and the Notice for its 22nd Annual General Meeting (AGM) for the Financial Year 2025-26. The AGM is scheduled for September 16, 2026, to be held virtually. The company's annual report emphasizes its commitment to quality care, patient-centricity, and expanding access to healthcare services. This year's report is also its inaugural Integrated Report, providing a comprehensive view of its strategy, governance, performance, and value creation. The report aligns with the International Integrated Reporting Framework and includes financial and non-financial information to offer stakeholders a holistic understanding of the company's operations and its response to evolving market dynamics.

Global Health Limited (GHL) has announced its 22nd Annual General Meeting (AGM) to be held on Wednesday, September 16, 2026, at 12:00 Noon IST via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting agenda includes adopting audited standalone and consolidated financial statements for FY26, declaring a final dividend of ₹0.50 per equity share, appointing a director, and approving remuneration for Cost Auditors, M/s. Ramanath Iyer & Co., for FY27 at ₹12.50 Lakhs.

Global Health Limited's Board of Directors, in a meeting held on July 30, 2026, approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board also approved the notice for the 22nd Annual General Meeting (AGM) scheduled for September 16, 2026, where shareholders will vote on a final dividend of ₹0.50 per equity share for FY 2025-26. The record date for this dividend is fixed as August 14, 2026. Additionally, the company appointed Mr. Pradeep Kumar Singh as Chief Digital Officer and approved a revised construction plan for its Guwahati hospital, increasing bed capacity from 400 to 650 beds. The trading window will reopen 48 hours after the results declaration.